Abstract
Editorial: Recent Advances in Cardiotoxicity Testing.
Highlights
Drug induced cardiotoxicity is a major cause of market withdrawal (Onakpoya et al, 2016)
The last decade has seen an explosion of cancer therapies, which while effective can lead to several cardiovascular toxicities
A close collaboration between cardiologists and oncologists had helped make these complications manageable ensuring that patients can be treated effectively (Campia et al, 2019)
Summary
Drug induced cardiotoxicity is a major cause of market withdrawal (Onakpoya et al, 2016). (2021) Editorial: Recent Advances in Cardiotoxicity Testing. In the last decade of the 20th century, eight non-cardiovascular drugs were withdrawn from clinical use because they prolonged the QT interval (Fermini and Fossa, 2003), resulting in ventricular arrhythmias and potentially sudden death.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.